Table of Content


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders


2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome


3. Executive Summary
3.1. Market Outlook
3.2. Source Outlook
3.3. Formulation Outlook
3.4. Application Outlook
3.5. Competitor Outlook


4. Market Overview
4.1. Introduction


5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges


6. United States Antithrombin Market, By Source
6.1. Introduction
6.2. Goat Milk
6.3. Human


7. United States Antithrombin Market, By Formulation
7.1. Introduction
7.2. Liquid
7.3. Lyophilized


8. United States Antithrombin Market, By Application
8.1. Introduction
8.2. Research and Diagnostics
8.3. Therapeutics


9. 360iResearch Competitive Strategic Window
9.1. Introduction
9.2. 360iResearch Competitive Strategic Window, by Source
9.3. 360iResearch Competitive Strategic Window, by Formulation
9.4. 360iResearch Competitive Strategic Window, by Application


10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. 360iResearch Market Ranking Analysis
10.3. 360iResearch Market Share Analysis
10.4. 360iResearch Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion


11. Company Usability Profiles
11.1. Dem ilac, Inc
11.2. Diapharma Group, Inc.
11.3. Lee Biosolutions, Inc
11.4. Octapharma AG
11.5. Scripps Laboratories, Inc.


12. Appendix
12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details



List of Figures



FIGURE 1. UNITED STATES ANTITHROMBIN MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES ANTITHROMBIN MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES ANTITHROMBIN MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES ANTITHROMBIN MARKET SIZE, BY SOURCE, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES ANTITHROMBIN MARKET, BY TYPE
FIGURE 8. UNITED STATES ANTITHROMBIN MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES ANTITHROMBIN MARKET SIZE GROWTH , 2017-2025 (USD MILLION)
FIGURE 10. UNITED STATES ANTITHROMBIN MARKET: MARKET DYNAMICS
FIGURE 11. UNITED STATES ANTITHROMBIN MARKET SIZE, BY SOURCE, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2019 VS 2025 (USD MILLION)
FIGURE 13. UNITED STATES ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTITHROMBIN MARKET SIZE, BY SOURCE, 2025
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTITHROMBIN MARKET SIZE, BY FORMULATION, 2025
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES ANTITHROMBIN MARKET SIZE, BY APPLICATION, 2025
FIGURE 17. UNITED STATES ANTITHROMBIN MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 18. UNITED STATES ANTITHROMBIN MARKET: 360IRESEARCH MARKET SHARE ANALYSIS


List of Tables



TABLE 1. UNITED STATES ANTITHROMBIN MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES ANTITHROMBIN MARKET SIZE, BY GOAT MILK, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES ANTITHROMBIN MARKET SIZE, BY HUMAN, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES ANTITHROMBIN MARKET SIZE, BY LIQUID, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES ANTITHROMBIN MARKET SIZE, BY LYOPHILIZED, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES ANTITHROMBIN MARKET SIZE, BY RESEARCH AND DIAGNOSTICS, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES ANTITHROMBIN MARKET SIZE, BY THERAPEUTICS, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES ANTITHROMBIN MARKET: SCORES
TABLE 9. UNITED STATES ANTITHROMBIN MARKET: BUSINESS STRATEGY
TABLE 10. UNITED STATES ANTITHROMBIN MARKET: PRODUCT SATISFACTION
TABLE 11. UNITED STATES ANTITHROMBIN MARKET: RANKING
TABLE 12. UNITED STATES ANTITHROMBIN MARKET: MERGER & ACQUISITION
TABLE 13. UNITED STATES ANTITHROMBIN MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 14. UNITED STATES ANTITHROMBIN MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 15. UNITED STATES ANTITHROMBIN MARKET: INVESTMENT & FUNDING
TABLE 16. UNITED STATES ANTITHROMBIN MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 17. UNITED STATES ANTITHROMBIN MARKET: EDITION DETAILS
TABLE 18. UNITED STATES ANTITHROMBIN MARKET: LICENSE DETAILS
TABLE 19. UNITED STATES ANTITHROMBIN MARKET: PRICING DETAILS